Infection/Condition,Type of Precaution,Duration of Precaution,Precautions/Comments,Table_Number
"Abscess Draining, major",Contact + Standard,Duration of illness,Until drainage stops or can be contained by dressing.,Table_1
"Abscess Draining, minor or limited",Standard,n/a,If dressing covers and contains drainage.,Table_1
Acquired human immunodeficiency syndrome (HIV),Standard,n/a,Postexposure chemoprophylaxis for some blood exposures [866].,Table_1
Actinomycosis,Standard,n/a,Not transmitted from person to person.,Table_1
"Adenovirus infection (see agent-specific guidance under Gastroenteritis , Conjunctivitis , Pneumonia )",n/a,n/a,n/a,Table_1
Amebiasis,Standard,n/a,Person-to-person transmission is rare. Transmission in settings for the mentally challenged and in a family group has been reported [1045]. Use care when handling diapered infants and mentally challenged persons [1046].,Table_1
Andes virus Andes virus [September 2024] Update: New precaution recommendations for Andes virus.,See comments,"Duration of precautions should be determined on a case-by-case basis, in conjunction with local, state, and federal health authorities. Factors that should be considered include, but are not limited to, presence of symptoms, date symptoms resolved, other conditions that would require specific precautions (e.g. tuberculosis, Clostridium difficile ) and available laboratory information.","Patient Placement: AIIR PPE: Gown , gloves, eye protection, N95® respirator or higher",Table_1
Anthrax,Standard,n/a,Infected patients do not generally pose a transmission risk.,Table_1
Anthrax Cutaneous,Standard,n/a,"Transmission through non-intact skin contact with draining lesions possible, therefore use Contact Precautions if large amount of uncontained drainage. Handwashing with soap and water preferable to use of waterless alcohol-based antiseptics since alcohol does not have sporicidal activity [983].",Table_1
Anthrax Pulmonary,Standard,n/a,Not transmitted from person to person.,Table_1
Anthrax Environmental: aerosolizable spore-containing powder or other substance,n/a,Until environment completely decontaminated,"Until decontamination of environment complete [203]. Wear respirator (N95 mask or PAPRs), protective clothing; decontaminate persons with powder on them ( Notice to Readers: Occupational Health Guidelines for Remediation Workers at Bacillus anthracis-Contaminated Sites — United States, 2001–2002 accessed September 2018). Hand hygiene: Handwashing for 30-60 seconds with soap and water or 2% chlorhexidine gluconate after spore contact (alcohol handrubs inactive against spores [983].) Postexposure prophylaxis following environmental exposure: 60 days of antimicrobials (either doxycycline, ciprofloxacin, or levofloxacin) and postexposure vaccine under IND.",Table_1
Antibiotic-associated colitis (see Clostridium difficile ),n/a,n/a,n/a,Table_1
"Arthropod-borne viral encephalitides (eastern, western, Venezuelan equine encephalomyelitis; St Louis, California encephalitis; West Nile Virus) and viral fevers (dengue, Oropouche, yellow fever, Colorado tick fever)",Standard,n/a,Install screens in windows and doors in endemic areas. Use DEET-containing mosquito repellants and clothing to cover extremities.,Table_1
Ascariasis,Standard,n/a,Not transmitted from person to person.,Table_1
Aspergillosis,Standard,n/a,Contact Precautions and Airborne if massive soft tissue infection with copious drainage and repeated irrigations required [154].,Table_1
"Avian influenza (see influenza, avian below)",n/a,n/a,n/a,Table_1
Babesiosis,Standard,n/a,"Not transmitted from person to person, except rarely by transfusion.",Table_2
"Blastomycosis, North American, cutaneous or pulmonary",Standard,n/a,Not transmitted from person to person.,Table_2
Botulism,Standard,n/a,Not transmitted from person to person.,Table_2
Bronchiolitis (see Respiratory Infections in infants and young children ),Contact + Standard,Duration of illness,Use mask according to Standard Precautions.,Table_2
"Brucellosis (undulant, Malta, Mediterranean fever)",Standard,n/a,"Not transmitted from person to person, except rarely via banked spermatozoa and sexual contact [1048, 1049]. Provide antimicrobial prophylaxis following laboratory exposure [1050].",Table_2
Campylobacter gastroenteritis (see Gastroenteritis ),n/a,n/a,n/a,Table_3
"Candidiasis, all forms including mucocutaneous",Standard,n/a,n/a,Table_3
Cat-scratch fever (benign inoculation lymphoreticulosis),Standard,n/a,Not transmitted from person to person.,Table_3
Cellulitis,Standard,n/a,n/a,Table_3
Chancroid (soft chancre) ( H. ducreyi ),Standard,n/a,Transmitted sexually from person to person.,Table_3
Chickenpox (see Varicella ),n/a,n/a,n/a,Table_3
Chlamydia trachomatis Conjunctivitis,Standard,n/a,n/a,Table_3
Chlamydia trachomatis Genital (lymphogranuloma venereum),Standard,n/a,n/a,Table_3
Chlamydia trachomatis Pneumonia (infants ≤3 mos. of age),Standard,n/a,n/a,Table_3
Chlamydia pneumoniae,Standard,n/a,"Outbreaks in institutionalized populations reported, rarely [1051, 1052].",Table_3
Cholera (see Gastroenteritis ),n/a,n/a,n/a,Table_3
Closed-cavity infection Open drain in place; limited or minor drainage,Standard,n/a,Contact Precautions if there is copious uncontained drainage.,Table_3
Closed-cavity infection No drain or closed drainage system in place,Standard,n/a,n/a,Table_3
Clostridium botulinum,Standard,n/a,Not transmitted from person to person.,Table_3
"Clostridium difficile (see Gastroenteritis , C. difficile )",Contact + Standard,Duration of illness,n/a,Table_3
Clostridium perfringens Food poisoning,Standard,n/a,Not transmitted from person to person.,Table_3
Clostridium perfringens Gas gangrene,Standard,n/a,Transmission from person to person rare; 1 outbreak in a surgical setting reported [1053]. Use Contact Precautions if wound drainage is extensive.,Table_3
Coccidioidomycosis (valley fever) Draining lesions,Standard,n/a,"Not transmitted from person to person except under extraordinary circumstances, because the infectious arthroconidial form of Coccidioides immitis is not produced in humans [1054].",Table_3
Coccidioidomycosis (valley fever) Pneumonia,Standard,n/a,"Not transmitted from person to person except under extraordinary circumstances, (e.g., inhalation of aerosolized tissue phase endospores during necropsy, transplantation of infected lung) because the infectious arthroconidial form of Coccidioides immitis is not produced in humans [1054, 1055].",Table_3
Colorado tick fever,Standard,n/a,Not transmitted from person to person.,Table_3
Congenital rubella,Contact + Standard,Until 1 yr of age,Standard Precautions if nasopharyngeal and urine cultures repeatedly negative after 3 mos. of age.,Table_3
Conjunctivitis Acute bacterial,Standard,n/a,n/a,Table_3
Conjunctivitis Acute bacterial Chlamydia,Standard,n/a,n/a,Table_3
Conjunctivitis Acute bacterial Gonococcal,Standard,n/a,n/a,Table_3
Conjunctivitis Acute viral (acute hemorrhagic),Contact + Standard,Duration of illness,"Adenovirus most common; enterovirus 70 [1056], Coxsackie virus A24 [1057] also associated with community outbreaks. Highly contagious; outbreaks in eye clinics, pediatric and neonatal settings, institutional settings reported. Eye clinics should follow Standard Precautions when handling patients with conjunctivitis. Routine use of infection control measures in the handling of instruments and equipment will prevent the occurrence of outbreaks in this and other settings. [460, 461, 814, 1058-1060].",Table_3
Corona virus associated with SARS (SARS-CoV) (see Severe Acute Respiratory Syndrome ),n/a,n/a,n/a,Table_3
Coxsackie virus disease (see enteroviral infection ),n/a,n/a,n/a,Table_3
"Creutzfeldt-Jakob disease (CJD, vCJD)",Standard,n/a,"Use disposable instruments or special sterilization/disinfection for surfaces, objects contaminated with neural tissue if CJD or vCJD suspected and has not been R/O; No special burial procedures. [1061]",Table_3
Croup (see Respiratory Infections in infants and young children ),n/a,n/a,n/a,Table_3
Crimean-Congo Fever (see Viral Hemorrhagic Fever ),,n/a,n/a,Table_3
Cryptococcosis,Standard,n/a,"Not transmitted from person to person, except rarely via tissue and corneal transplant. [1062, 1063]",Table_3
Cryptosporidiosis (see Gastroenteritis ),n/a,n/a,n/a,Table_3
Cysticercosis,Standard,n/a,Not transmitted from person to person.,Table_3
"Cytomegalovirus infection, including in neonates and immunosuppressed patients",Standard,n/a,No additional precautions for pregnant HCWs.,Table_3
Decubitus ulcer (see Pressure Ulcer ),n/a,n/a,n/a,Table_4
Dengue fever,Standard,n/a,Not transmitted from person to person.,Table_4
"Diarrhea, acute-infective etiology suspected (see Gastroenteritis )",n/a,n/a,n/a,Table_4
Diphtheria Cutaneous,Contact + Standard,Until off antimicrobial treatment and culture-negative,Until 2 cultures taken 24 hours apart negative.,Table_4
Diphtheria Pharyngeal,Droplet + Standard,Until off antimicrobial treatment and culture-negative,Until 2 cultures taken 24 hours apart negative.,Table_4
Ebola virus (see Viral Hemorrhagic Fevers ),n/a,n/a,,Table_5
Echinococcosis (hydatidosis),Standard,n/a,Not transmitted from person to person.,Table_5
Echovirus (see Enteroviral Infection ),n/a,n/a,n/a,Table_5
Encephalitis or encephalomyelitis (see specific etiologic agents),n/a,n/a,n/a,Table_5
Endometritis (endomyometritis),Standard,n/a,n/a,Table_5
"Enterobiasis (pinworm disease, oxyuriasis)",Standard,n/a,n/a,Table_5
Enterococcus species (see Multidrug-Resistant Organisms if epidemiologically significant or vancomycin-resistant),n/a,n/a,n/a,Table_5
"Enterocolitis, C. difficile (see Gastroenteritis, C. difficile )",n/a,n/a,n/a,Table_5
"Enteroviral infections (i.e., Group A and B Coxsackie viruses and Echo viruses) (excludes polio virus)",Standard,n/a,Use Contact Precautions for diapered or incontinent children for duration of illness and to control institutional outbreaks.,Table_5
"Epiglottitis, due to Haemophilus influenzae type b",Droplet + Standard,Until 24 hours after initiation of effective therapy,See specific disease agents for epiglottitis due to other etiologies.,Table_5
"Epstein-Barr virus infection, including infectious mononucleosis",Standard,n/a,n/a,Table_5
Erythema infectiosum (also see Parvovirus B19 ),n/a,n/a,n/a,Table_5
Escherichia coli gastroenteritis (see Gastroenteritis ),n/a,n/a,n/a,Table_5
Food poisoning Botulism,Standard,n/a,Not transmitted from person to person.,Table_6
Food poisoning C. perfringens or welchii,Standard,n/a,Not transmitted from person to person.,Table_6
Food poisoning Staphylococcal,Standard,n/a,Not transmitted from person to person.,Table_6
"Furunculosis, staphylococcal",Standard,n/a,Contact if drainage not controlled. Follow institutional policies if MRSA.,Table_6
"Furunculosis, staphylococcal Infants and young children",Contact + Standard,"Duration of illness (with wound lesions, until wounds stop draining)",n/a,Table_6
Gangrene (gas gangrene),Standard,n/a,Not transmitted from person to person.,Table_7
Gastroenteritis,Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks for gastroenteritis caused by all of the agents below.,Table_7
Gastroenteritis Adenovirus,Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks.,Table_7
Gastroenteritis Campylobacter species,Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks.,Table_7
Gastroenteritis Cholera ( Vibrio cholerae ),Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks.,Table_7
Gastroenteritis C. difficile,Contact + Standard,Duration of illness,"Discontinue antibiotics if appropriate. Do not share electronic thermometers; [853, 854] ensure consistent environmental cleaning and disinfection. Hypochlorite solutions may be required for cleaning if transmission continues [847]. Handwashing with soap and water preferred because of the absence of sporicidal activity of alcohol in waterless antiseptic handrubs [983].",Table_7
Gastroenteritis Cryptosporidium species,Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks.,Table_7
Gastroenteritis E. coli Enteropathogenic O157:H7 and other Shiga toxin-producing strains,Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks.,Table_7
Gastroenteritis E. coli Other species,Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks.,Table_7
Gastroenteritis Giardia lamblia,Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks.,Table_7
Gastroenteritis Noroviruses,Update: Contact + Standard,n/a,"Use Contact Precautions for a minimum of 48 hours after the resolution of symptoms or to control institutional outbreaks. Persons who clean areas heavily contaminated with feces or vomitus may benefit from wearing masks since virus can be aerosolized from these body substances [142, 147 148]; ensure consistent environmental cleaning and disinfection with focus on restrooms even when apparently unsoiled [273, 1064]. Hypochlorite solutions may be required when there is continued transmission [290-292]. Alcohol is less active, but there is no evidence that alcohol antiseptic handrubs are not effective for hand decontamination [294]. Cohorting of affected patients to separate airspaces and toilet facilities may help interrupt transmission during outbreaks. Gastroenteritis, Noroviruses Precaution Update [April 2019] Update: The Type of Precaution was updated from “Standard” to “Contact + Standard” to align with Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings (2011) .",Table_7
Gastroenteritis Rotavirus,Contact + Standard,Duration of illness,"Ensure consistent environmental cleaning and disinfection and frequent removal of soiled diapers. Prolonged shedding may occur in both immunocompetent and immunocompromised children and the elderly [932, 933].",Table_7
Gastroenteritis Salmonella species (including S. typhi ),Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks.,Table_7
Gastroenteritis Shigella species (Bacillary dysentery),Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks.,Table_7
Gastroenteritis Vibrio parahaemolyticus,Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks.,Table_7
Gastroenteritis Viral (if not covered elsewhere),Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks.,Table_7
Gastroenteritis Yersinia enterocolitica,Standard,n/a,Use Contact Precautions for diapered or incontinent persons for the duration of illness or to control institutional outbreaks.,Table_7
German measles (see Rubella ; see Congenital Rubella ),n/a,n/a,n/a,Table_7
Giardiasis (see Gastroenteritis ),n/a,n/a,n/a,Table_7
"Gonococcal ophthalmia neonatorum (gonorrheal ophthalmia, acute conjunctivitis of newborn)",Standard,n/a,n/a,Table_7
Gonorrhea,Standard,n/a,n/a,Table_7
"Granuloma inguinale (Donovanosis, granuloma venereum)",Standard,n/a,n/a,Table_7
Guillain-Barré syndrome,Standard,n/a,Not an infectious condition.,Table_7
Haemophilus influenzae (see disease-specific recommendations),n/a,n/a,n/a,Table_8
"Hand, foot, and mouth disease (see Enteroviral Infection )",n/a,n/a,n/a,Table_8
Hansen’s Disease (see Leprosy ),n/a,n/a,n/a,Table_8
Hantavirus pulmonary syndrome,Standard,n/a,Not transmitted from person to person.,Table_8
Helicobacter pylori,Standard,n/a,n/a,Table_8
"Hepatitis, viral Type A",Standard,n/a,Provide hepatitis A vaccine postexposure as recommended. [1065],Table_8
"Hepatitis, viral Type A-Diapered or incontinent patients",Contact + Standard,n/a,"Maintain Contact Precautions in infants and children <3 years of age for duration of hospitalization; for children 3-14 yrs. of age for 2 weeks after onset of symptoms; >14 yrs. of age for 1 week after onset of symptoms [833, 1066, 1067].",Table_8
"Hepatitis, viral Type B-HBsAg positive; acute or chronic",Standard,n/a,See specific recommendations for care of patients in hemodialysis centers. [778],Table_8
"Hepatitis, viral Type C and other unspecified non-A, non-B",Standard,n/a,See specific recommendations for care of patients in hemodialysis centers. [778],Table_8
"Hepatitis, viral Type D (seen only with hepatitis B)",Standard,n/a,n/a,Table_8
"Hepatitis, viral Type E",Standard,n/a,Use Contact Precautions for diapered or incontinent individuals for the duration of illness. [1068],Table_8
"Hepatitis, viral Type G",Standard,n/a,n/a,Table_8
Herpangina (see Enteroviral Infection ),n/a,n/a,n/a,Table_8
Hookworm,Standard,n/a,n/a,Table_8
Herpes simplex ( Herpesvirus hominis ) Encephalitis,Standard,n/a,n/a,Table_8
"Herpes simplex (Herpesvirus hominis) Mucocutaneous, disseminated or primary, severe",Contact + Standard,Until lesions dry and crusted,n/a,Table_8
"Herpes simplex (Herpesvirus hominis) Mucocutaneous, recurrent (skin, oral, genital)",Standard,n/a,n/a,Table_8
Herpes simplex (Herpesvirus hominis) Neonatal,Contact + Standard,Until lesions dry and crusted,"Also, for asymptomatic, exposed infants delivered vaginally or by C-section and if mother has active infection and membranes have been ruptured for more than 4 to 6 hours until infant surface cultures obtained at 24-36 hours of age negative after 48 hours incubation. [1069, 1070]",Table_8
Herpes zoster (varicella-zoster) (shingles) Disseminated disease in any patient Localized disease in immunocompromised patient until disseminated infection ruled out,Airborne + Contact + Standard,Duration of illness,Susceptible HCWs should not enter room if immune caregivers are available; no recommendation for protection of immune HCWs; no recommendation for type of protection (i.e. surgical mask or respirator) for susceptible HCWs.,Table_8
Herpes zoster (varicella-zoster) (shingles) Localized in patient with intact immune system with lesions that can be contained/covered,Standard,Until lesions dry and crusted,Susceptible HCWs should not provide direct patient care when other immune caregivers are available.,Table_8
Histoplasmosis,Standard,n/a,Not transmitted from person to person.,Table_8
Human immunodeficiency virus (HIV),Standard,n/a,Postexposure chemoprophylaxis for some blood exposures [866].,Table_8
Human metapneumovirus,Contact + Standard,Duration of illness,"HAI reported [1071], but route of transmission not established [823]. Assumed to be Contact transmission as for RSV since the viruses are closely related and have similar clinical manifestations and epidemiology. Wear masks according to Standard Precautions.",Table_8
Impetigo,Contact + Standard,Until 24 hours after initiation of effective therapy,n/a,Table_9
Infectious mononucleosis,Standard,n/a,n/a,Table_9
Influenza Human (seasonal influenza),n/a,n/a,See Prevention Strategies for Seasonal Influenza in Healthcare Settings (accessed September 2018). [Current version of this document may differ from original.] for current seasonal influenza guidance.,Table_9
"Influenza Avian (e.g., H5N1, H7, H9 strains)",n/a,n/a,"See [This link is no longer active: www.cdc.gov/flu/avian/professional/infect-control.htm. Similar information may be found at Interim Guidance for Infection Control Within Healthcare Settings When Caring for Confirmed Cases, Probable Cases, and Cases Under Investigation for Infection with Novel Influenza A Viruses Associated with Severe Disease (accessed September 2018).] for current avian influenza guidance.",Table_9
Influenza Pandemic Influenza (also a human influenza virus),Droplet + Standard,n/a,"See [This link is no longer active: http://www.pandemicflu.gov. Similar information may be found at Interim Guidance for Infection Control Within Healthcare Settings When Caring for Confirmed Cases, Probable Cases, and Cases Under Investigation for Infection with Novel Influenza A Viruses Associated with Severe Disease (accessed September 2018).] for current pandemic influenza guidance.",Table_9
Kawasaki syndrome,Standard,n/a,Not an infectious condition.,Table_10
Lassa fever (see Viral Hemorrhagic Fevers ),n/a,n/a,n/a,Table_11
Legionnaires’ disease,Standard,n/a,Not transmitted from person to person.,Table_11
Leprosy,Standard,n/a,n/a,Table_11
Leptospirosis,Standard,n/a,Not transmitted from person to person.,Table_11
Lice Head (pediculosis),Contact + Standard,Until 24 hours after initiation of effective therapy,See [This link is no longer active: https://www.cdc.gov/ncidod/dpd/parasites/lice/default.htm. Similar information may be found at CDC’s Parasites – Lice (accessed September 2018).],Table_11
Lice Body,Standard,n/a,Transmitted person-to-person through infested clothing. Wear gown and gloves when removing clothing; bag and wash clothes according to CDC guidance Parasites – Lice (accessed September 2018).,Table_11
Lice Pubic,Standard,n/a,Transmitted person-to-person through sexual contact. See CDC’s Parasites – Lice (accessed September 2018).,Table_11
Listeriosis (listeria monocytogenes),Standard,n/a,Person-to-person transmission rare; cross-transmission in neonatal settings reported. [1072-1075],Table_11
Lyme disease,Standard,n/a,Not transmitted from person to person.,Table_11
Lymphocytic choriomeningitis,Standard,n/a,Not transmitted from person to person.,Table_11
Lymphogranuloma venereum,Standard,n/a,n/a,Table_11
Malaria,Standard,n/a,"Not transmitted from person to person, except through transfusion rarely and through a failure to follow Standard Precautions during patient care. [1076-1079] Install screens in windows and doors in endemic areas. Use DEET- containing mosquito repellants and clothing to cover extremities.",Table_12
Marburg virus disease (see Viral Hemorrhagic Fevers ),n/a,n/a,n/a,Table_12
Measles (rubeola),Airborne + Standard,4 days after onset of rash; duration of illness in immune compromised,"Interim Measles Infection Control [July 2019] See Interim Infection Prevention and Control Recommendations for Measles in Healthcare Settings Susceptible healthcare personnel (HCP) should not enter room if immune care providers are available; regardless of presumptive evidence of immunity, HCP should use respiratory protection that is at least as protective as a fit-tested, NIOSH-certified N95 respirator upon entry into the patient’s room or care area. For exposed susceptibles, postexposure vaccine within 72 hours or immune globulin within 6 days when available [17, 1032, 1034]. Place exposed susceptible patients on Airborne Precautions and exclude susceptible healthcare personnel.",Table_12
"Melioidosis, all forms",Standard,n/a,Not transmitted from person to person.,Table_12
Meningitis Aseptic (nonbacterial or viral; also see Enteroviral infections ),Standard,n/a,Contact for infants and young children.,Table_12
"Meningitis Bacterial, gram-negative enteric, in neonates",Standard,n/a,n/a,Table_12
Meningitis Fungal,Standard,n/a,n/a,Table_12
"Meningitis Haemophilus Influenzae , type b known or suspected",Droplet + Standard,Until 24 hours after initiation of effective therapy,n/a,Table_12
Meningitis Listeria monocytogenes (See Listeriosis ),Standard,n/a,n/a,Table_12
Meningitis Neisseria meningitidis (meningococcal) known or suspected,Droplet + Standard,Until 24 hours after initiation of effective therapy,See Meningococcal Disease below.,Table_12
Meningitis Streptococcus pneumoniae,Standard,n/a,n/a,Table_12
Meningitis M. tuberculosis,Standard,n/a,"Concurrent, active pulmonary disease or draining cutaneous lesions may necessitate addition of Contact and/or Airborne. For children, Airborne Precautions until active tuberculosis ruled out in visiting family members (see Tuberculosis below). [42]",Table_12
Meningitis Other diagnosed bacterial,Standard,n/a,n/a,Table_12
"Meningococcal disease: sepsis, pneumonia, Meningitis",Droplet + Standard,Until 24 hours after initiation of effective therapy,"Postexposure chemoprophylaxis for household contacts, HCWs exposed to respiratory secretions; postexposure vaccine only to control outbreaks. [15, 17]",Table_12
Molluscum contagiosum,Standard,n/a,n/a,Table_12
Monkeypox,,,See CDC’s Monkeypox website (accessed May 2022) for information on infection prevention and control.,Table_12
Mucormycosis,Standard,n/a,n/a,Table_12
"Multidrug-resistant organisms (MDROs), infection or colonization (e.g., MRSA, VRE, VISA/VRSA, ESBLs, resistant S. pneumoniae )",Contact + Standard,n/a,"MDROs judged by the infection control program, based on local, state, regional, or national recommendations, to be of clinical and epidemiologic significance. Contact Precautions recommended in settings with evidence of ongoing transmission, acute care settings with increased risk for transmission or wounds that cannot be contained by dressings. See recommendations for management options in Management of Multidrug-Resistant Organisms In Healthcare Settings, 2006 [870]. Contact state health department for guidance regarding new or emerging MDRO.",Table_12
Mumps (infectious parotitis),Droplet + Standard,Until 5 days after the onset of swelling,Mumps [October 2017] Update: The Healthcare Infection Control Practices Advisory Committee (HICPAC) voted to change the recommendation of isolation for persons with mumps from 9 days to 5 days based on this 2008 MMWR report Updated Recommendations for Isolation of Persons with Mumps (accessed September 2018). After onset of swelling; susceptible HCWs should not provide care if immune caregivers are available. The below note has been superseded by the above recommendation update Note: (Recent assessment of outbreaks in healthy 18-24 year olds has indicated that salivary viral shedding occurred early in the course of illness and that 5 days of isolation after onset of parotitis may be appropriate in community settings; however the implications for healthcare personnel and high-risk patient populations remain to be clarified.),Table_12
"Mycobacteria, nontuberculosis (atypical)",n/a,Not transmitted person-to-person.,n/a,Table_12
"Mycobacteria, nontuberculosis (atypical)",Pulmonary,Standard,n/a,Table_12
"Mycobacteria, nontuberculosis (atypical)",Wound,Standard,n/a,Table_12
Mycoplasma pneumonia,Droplet + Standard,Duration of Illness,n/a,Table_12
Necrotizing enterocolitis,Standard,n/a,Contact Precautions when cases clustered temporally [1080-1083].,Table_13
Nipah virus Nipah virus [September 2024] Update: New precaution recommendations for Nipah virus.,See comments,"Duration of precautions should be determined on a case-by-case basis, in conjunction with local, state, and federal health authorities. Factors that should be considered include, but are not limited to, presence of symptoms, date symptoms resolved, other conditions that would require specific precautions (e.g. tuberculosis, Clostridium difficile ) and available laboratory information.","Patient Placement: AIIR PPE: If suspect Nipah case and clinically stable: gown , gloves, eye protection, N95® respirator or higher If suspect Nipah and clinically unstable (e.g. hemodynamic instability, vomiting) OR confirmed Nipah case regardless of clinical stability: use PPE according to guidance for confirmed patients and clinically unstable patients suspected to have VHF",Table_13
"Nocardiosis, draining lesions, or other presentations",Standard,n/a,Not transmitted person-to-person.,Table_13
Norovirus (see Gastroenteritis ),n/a,n/a,n/a,Table_13
Norwalk agent Gastroenteritis (see Gastroenteritis ),n/a,n/a,n/a,Table_13
Orf,Standard,n/a,n/a,Table_14
"Parainfluenza virus infection, respiratory in infants and young children",Contact + Standard,Duration of illness,"Viral shedding may be prolonged in immunosuppressed patients [1009, 1010]. Reliability of antigen testing to determine when to remove patients with prolonged hospitalizations from Contact Precautions uncertain.",Table_15
Parvovirus B19 (Erythema infectiosum),Droplet + Standard,n/a,"Maintain precautions for duration of hospitalization when chronic disease occurs in an immunocompromised patient. For patients with transient aplastic crisis or red-cell crisis, maintain precautions for 7 days. Duration of precautions for immunosuppressed patients with persistently positive PCR not defined, but transmission has occurred [929].",Table_15
Pediculosis (lice),Contact + Standard,Until 24 hours after initiation of effective therapy after treatment,n/a,Table_15
Pertussis (whooping cough),Droplet + Standard,Until 5 days after initiation of effective antibiotic therapy,Single patient room preferred. Cohorting an option. Postexposure chemoprophylaxis for household contacts and HCWs with prolonged exposure to respiratory secretions [863]. Recommendations for Tdap vaccine in adults under development. Tdap Vaccine Recommendations [2018] Update: Current recommendations can be found at Tdap / Td ACIP Vaccine Recommendations (accessed September 2018).,Table_15
Pinworm infection (Enterobiasis),Standard,n/a,n/a,Table_15
Plague ( Yersinia pestis ) Bubonic,Standard,n/a,n/a,Table_15
Plague ( Yersinia pestis ) Pneumonic,Droplet + Standard,Until 48 hours after initiation of effective antibiotic therapy,Antimicrobial prophylaxis for exposed HCW [207].,Table_15
Pneumonia Adenovirus,Droplet + Contact + Standard,Duration of illness,"Outbreaks in pediatric and institutional settings reported [376, 1084-1086]. In immunocompromised hosts, extend duration of Droplet and Contact Precautions due to prolonged shedding of virus. [931]",Table_15
Pneumonia Bacterial not listed elsewhere (including gram-negative bacterial),Standard,n/a,n/a,Table_15
"Pneumonia B. cepacia in patients with CF, including respiratory tract colonization",Contact + Standard,Unknown,Avoid exposure to other persons with CF; private room preferred. Criteria for D/C precautions not established. See CF Foundation guideline. [20],Table_15
Pneumonia B. cepacia in patients without CF (see Multidrug-Resistant Organisms ),n/a,n/a,n/a,Table_15
Pneumonia Chlamydia,Standard,n/a,n/a,Table_15
Pneumonia Fungal,Standard,n/a,n/a,Table_15
"Pneumonia Haemophilus influenzae , type b Adults",Standard,n/a,n/a,Table_15
"Pneumonia Haemophilus influenzae , type b Infants and children",Droplet + Standard,Until 24 hours after initiation of effective therapy,n/a,Table_15
Pneumonia Legionella spp.,Standard,n/a,n/a,Table_15
Pneumonia . Meningococcal,Droplet + Standard,Until 24 hours after initiation of effective therapy,See Meningococcal Disease above.,Table_15
Pneumonia Multidrug-resistant bacterial (see Multidrug-Resistant Organisms ),n/a,n/a,n/a,Table_15
Pneumonia Mycoplasma (primary atypical Pneumonia),Droplet + Standard,Duration of illness,n/a,Table_15
Pneumonia Pneumococcal pneumonia,Standard,n/a,"Use Droplet Precautions if evidence of transmission within a patient care unit or facility. [196-198, 1087]",Table_15
Pneumonia Pneumocystis jiroveci ( Pneumocystis carinii ),Standard,n/a,Avoid placement in the same room with an immunocompromised patient.,Table_15
Pneumonia Staphylococcus aureus,Standard,n/a,"For MRSA, see MDROs .",Table_15
"Pneumonia Streptococcus , group A Adults",Droplet + Standard,Until 24 hours after initiation of effective therapy,See Streptococcal Disease (group A Streptococcus ) below Contact Precautions if skin lesions present.,Table_15
"Pneumonia Streptococcus , group A Infants and young children",Droplet + Standard,Until 24 hours after initiation of effective therapy,Contact Precautions if skin lesions present.,Table_15
Pneumonia Varicella-Zoster (See Varicella-Zoster ),n/a,n/a,n/a,Table_15
Pneumonia Viral Adults,Standard,n/a,n/a,Table_15
"Pneumonia Viral Infants and young children (see Respiratory Infectious Disease, acute , or specific viral agent)",n/a,n/a,n/a,Table_15
Poliomyelitis,Contact + Standard,Duration of illness,n/a,Table_15
"Pressure ulcer (decubitus ulcer, pressure sore) infected Major",Contact + Standard,Duration of illness,Until drainage stops or can be contained by dressing.,Table_15
"Pressure ulcer (decubitus ulcer, pressure sore) infected Minor or limited",Standard,n/a,If dressing covers and contains drainage.,Table_15
Prion disease (See Creutzfeld-Jacob Disease ),n/a,n/a,n/a,Table_15
Psittacosis (ornithosis) ( Chlamydia psittaci ),Standard,n/a,Not transmitted from person to person.,Table_15
Q fever,Standard,n/a,n/a,Table_16
Rabies,Standard,n/a,"Person to person transmission rare; transmission via corneal, tissue and organ transplants has been reported [539, 1088]. If patient has bitten another individual or saliva has contaminated an open wound or mucous membrane, wash exposed area thoroughly and administer postexposure prophylaxis. [1089]",Table_17
"Rat-bite fever ( Streptobacillus moniliformis disease, Spirillum minus disease)",Standard,n/a,Not transmitted from person to person.,Table_17
Relapsing fever,Standard,n/a,Not transmitted from person to person.,Table_17
Resistant bacterial infection or colonization (see Multidrug-Resistant Organisms ),n/a,n/a,n/a,Table_17
"Respiratory infectious disease, acute (if not covered elsewhere) Adults",Standard,n/a,n/a,Table_17
"Respiratory infectious disease, acute (if not covered elsewhere) Infants and young children",Contact + Standard,Duration of illness,Also see syndromes or conditions listed in Table 2.,Table_17
"Respiratory syncytial virus infection, in infants, young children and immunocompromised adults",Contact + Standard,Duration of illness,"Wear mask according to Standard Precautions [24] CB [116, 117]. In immunocompromised patients, extend the duration of Contact Precautions due to prolonged shedding [928]. Reliability of antigen testing to determine when to remove patients with prolonged hospitalizations from Contact Precautions uncertain.",Table_17
Reye’s syndrome,Standard,n/a,Not an infectious condition.,Table_17
Rheumatic fever,Standard,n/a,Not an infectious condition.,Table_17
Rhinovirus,Droplet + Standard,Duration of illness,"Droplet most important route of transmission [104 1090]. Outbreaks have occurred in NICUs and LTCFs [413, 1091, 1092]. Add Contact Precautions if copious moist secretions and close contact likely to occur (e.g., young infants) [111, 833].",Table_17
"Rickettsial fevers, tickborne (Rocky Mountain spotted fever, tickborne Typhus fever)",Standard,n/a,"Not transmitted from person to person except through transfusion, rarely.",Table_17
Rickettsialpox (vesicular rickettsiosis),Standard,n/a,Not transmitted from person to person.,Table_17
"Ringworm (dermatophytosis, dermatomycosis, tinea)",Standard,n/a,"Rarely, outbreaks have occurred in healthcare settings, (e.g., NICU [1093], rehabilitation hospital [1094]. Use Contact Precautions for outbreak.",Table_17
Rocky Mountain spotted fever,Standard,n/a,"Not transmitted from person to person except through transfusion, rarely.",Table_17
Roseola infantum (exanthem subitum; caused by HHV-6),Standard,n/a,n/a,Table_17
Rotavirus infection (see Gastroenteritis ),n/a,n/a,n/a,Table_17
Rubella (German measles) (also see Congenital Rubella ),Droplet + Standard,Until 7 days after onset of rash,"Susceptible HCWs should not enter room if immune caregivers are available. No recommendation for wearing face protection (e.g., a surgical mask) if immune. Pregnant women who are not immune should not care for these patients [17, 33]. Administer vaccine within 3 days of exposure to susceptible men and non-pregnant susceptible women. Place exposed susceptible patients on Droplet Precautions; exclude susceptible healthcare personnel from duty from day 5 after first exposure to day 21 after last exposure, regardless of postexposure vaccine.",Table_17
Rubeola (see Measles ),n/a,n/a,n/a,Table_17
Salmonellosis (see Gastroenteritis ),n/a,n/a,n/a,Table_18
Scabies,Contact + Standard,Until 24 hours after initiation of effective therapy,n/a,Table_18
"Scalded skin syndrome, staphylococcal",Contact + Standard,Duration of illness,"See Staphylococcal Disease, scalded skin syndrome below.",Table_18
Schistosomiasis (bilharziasis),Standard,n/a,n/a,Table_18
Severe acute respiratory syndrome (SARS),Airborne + Droplet + Contact + Standard,"Duration of illness plus 10 days after resolution of fever, provided respiratory symptoms are absent or improving","Airborne preferred; Droplet if AIIR unavailable. N95 or higher respiratory protection; surgical mask if N95 unavailable; eye protection (goggles, face shield); aerosol-generating procedures and “supershedders” highest risk for transmission via small droplet nuclei and large droplets [93, 94, 96]. Vigilant environmental disinfection (see [This link is no longer active: www.cdc.gov/ncidod/sars. Similar information may be found at CDC Severe Acute Respiratory Syndrome (SARS) (accessed September 2018).])",Table_18
Shigellosis (see Gastroenteritis ),n/a,n/a,n/a,Table_18
Smallpox (variola; see Vaccinia for management of vaccinated persons),Airborne + Contact + Standard,Duration of illness,"Until all scabs have crusted and separated (3-4 weeks). Non-vaccinated HCWs should not provide care when immune HCWs are available; N95 or higher respiratory protection for susceptible and successfully vaccinated individuals; postexposure vaccine within 4 days of exposure protective [108, 129, 1038-1040].",Table_18
Sporotrichosis,Standard,n/a,n/a,Table_18
Spirillum minor disease (rat-bite fever),Standard,n/a,Not transmitted from person to person.,Table_18
"Staphylococcal disease ( S. aureus ) Skin, wound, or burn Major",Contact + Standard,Duration of illness,Until drainage stops or can be contained by dressing.,Table_18
"Staphylococcal disease ( S. aureus ) Skin, wound, or burn Minor or limited",Standard,n/a,If dressing covers and contains drainage adequately.,Table_18
Staphylococcal disease ( S. aureus ) Enterocolitis,Standard,n/a,Use Contact Precautions for diapered or incontinent children for duration of illness.,Table_18
Staphylococcal disease ( S. aureus ) Multidrug-resistant (see Multidrug-Resistant Organisms ),n/a,n/a,n/a,Table_18
Staphylococcal disease ( S. aureus ) Pneumonia,Standard,n/a,n/a,Table_18
Staphylococcal disease ( S. aureus ) Scalded skin syndrome,Contact + Standard,Duration of illness,"Consider healthcare personnel as potential source of nursery, NICU outbreak [1095].",Table_18
Staphylococcal disease ( S. aureus ) Toxic shock syndrome,Standard,n/a,n/a,Table_18
Streptobacillus moniliformis disease (rat-bite fever),Standard,n/a,Not transmitted from person to person.,Table_18
"Streptococcal disease (group A Streptococcus ) Skin, wound, or burn Major",Contact + Droplet + Standard,Until 24 hours after initiation of effective therapy,Until drainage stops or can be contained by dressing.,Table_18
"Streptococcal disease (group A Streptococcus ) Skin, wound, or burn Minor or limited",Standard,n/a,If dressing covers and contains drainage.,Table_18
Streptococcal disease (group A Streptococcus ) Endometritis (puerperal sepsis),Standard,n/a,n/a,Table_18
Streptococcal disease (group A Streptococcus ) Pharyngitis in infants and young children,Droplet + Standard,Until 24 hours after initiation of effective therapy,n/a,Table_18
Streptococcal disease (group A Streptococcus ) Pneumonia,Droplet + Standard,Until 24 hours after initiation of effective therapy,n/a,Table_18
Streptococcal disease (group A Streptococcus ) Scarlet fever in infants and young children,Droplet + Standard,Until 24 hours after initiation of effective therapy,n/a,Table_18
Streptococcal disease (group A Streptococcus ) Serious invasive disease,Droplet + Standard,Until 24 hours after initiation of effective therapy,"Outbreaks of serious invasive disease have occurred secondary to transmission among patients and healthcare personnel [162, 972, 1096-1098]. Contact Precautions for draining wound as above; follow recommendations for antimicrobial prophylaxis in selected conditions [160].",Table_18
"Streptococcal disease (group B Streptococcus ), neonatal",Standard,n/a,n/a,Table_18
Streptococcal disease (not group A or B) unless covered elsewhere Multidrug-resistant (see Multidrug-Resistant Organisms ),n/a,n/a,n/a,Table_18
Strongyloidiasis,Standard,n/a,n/a,Table_18
Syphilis Latent (tertiary) and seropositivity without lesions,Standard,n/a,n/a,Table_18
"Syphilis Skin and mucous membrane, including congenital, primary, Secondary",Standard,n/a,n/a,Table_18
Tapeworm disease Hymenolepis nana,Standard,n/a,Not transmitted from person to person.,Table_19
Tapeworm disease Taenia solium (pork),Standard,n/a,n/a,Table_19
Tapeworm disease Other,Standard,n/a,n/a,Table_19
Tetanus,Standard,n/a,Not transmitted from person to person.,Table_19
"Tinea (e.g., dermatophytosis, dermatomycosis, ringworm)",Standard,n/a,Rare episodes of person-to-person transmission.,Table_19
Toxoplasmosis,Standard,n/a,"Transmission from person to person is rare; vertical transmission from mother to child, transmission through organs and blood transfusion rare.",Table_19
"Toxic shock syndrome (staphylococcal disease, streptococcal disease)",Standard,n/a,Droplet Precautions for the first 24 hours after implementation of antibiotic therapy if Group A Streptococcus is a likely etiology.,Table_19
"Trachoma, acute",Standard,n/a,n/a,Table_19
"Transmissible spongiform encephalopathy (see Creutzfeld-Jacob disease, CJD, vCJD )",n/a,n/a,n/a,Table_19
Trench mouth (Vincent’s angina),Standard,n/a,n/a,Table_19
Trichinosis,Standard,n/a,n/a,Table_19
Trichomoniasis,Standard,n/a,n/a,Table_19
Trichuriasis (whipworm disease),Standard,n/a,n/a,Table_19
"Tuberculosis ( M. tuberculosis ) Extrapulmonary, draining lesion",Airborne + Contact + Standard,n/a,"Discontinue precautions only when patient is improving clinically, and drainage has ceased or there are 3 consecutive negative cultures of continued drainage [1025, 1026]. Examine for evidence of active pulmonary tuberculosis.",Table_19
"Tuberculosis ( M. tuberculosis ) Extrapulmonary, no draining lesion, Meningitis",Standard,n/a,"Examine for evidence of pulmonary tuberculosis. For infants and children, use Airborne until active pulmonary tuberculosis in visiting family members ruled out. [42]",Table_19
"Tuberculosis ( M. tuberculosis ) Pulmonary or laryngeal disease, confirmed",Airborne + Standard,n/a,"Discontinue precautions only when patient on effective therapy is improving clinically and has 3 consecutive sputum smears negative for acid-fast bacilli collected on separate days ( MMWR 2005; 54: RR-17 Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005 ) (accessed September 2018) [12].",Table_19
"Tuberculosis ( M. tuberculosis ) Pulmonary or laryngeal disease, suspected",Airborne + Standard,n/a,"Discontinue precautions only when the likelihood of infectious TB disease is deemed negligible, and either there is another diagnosis that explains the clinical syndrome, or the results of 3 sputum smears for AFB are negative. Each of the 3 sputum specimens should be collected 8 -24 hours apart, and at least 1 should be an early morning specimen.",Table_19
Tuberculosis ( M. tuberculosis ) Skin-test positive with no evidence of current active disease,Standard,n/a,n/a,Table_19
Tularemia Draining lesion,Standard,n/a,Not transmitted from person to person.,Table_19
Tularemia Pulmonary,Standard,n/a,Not transmitted from person to person.,Table_19
Typhoid ( Salmonella typhi ) fever (see Gastroenteritis ),n/a,n/a,n/a,Table_19
Typhus Rickettsia prowazekii (Epidemic or Louse-borne Typhus),Standard,n/a,Transmitted from person to person through close personal or clothing contact.,Table_19
Typhus Rickettsia typhi,Standard,n/a,Not transmitted from person to person.,Table_19
"Urinary tract infection (including pyelonephritis), with or without urinary catheter",Standard,n/a,n/a,Table_20
Vaccinia,n/a,n/a,"Only vaccinated HCWs have contact with active vaccination sites and care for persons with adverse vaccinia events; if unvaccinated, only HCWs without contraindications to vaccine may provide care.",Table_21
Vaccinia Vaccination site care (including autoinoculated areas),Standard,n/a,"Vaccination recommended for vaccinators; for newly vaccinated HCWs: semi-permeable dressing over gauze until scab separates, with dressing change as fluid accumulates, ~3-5 days; gloves, hand hygiene for dressing change; vaccinated HCW or HCW without contraindication to vaccine for dressing changes. [205, 221, 225].",Table_21
Vaccinia (adverse events following vaccination) Eczema vaccinatum,Contact + Standard,"Until lesions dry and crusted, scabs separated",For contact with virus-containing lesions and exudative material.,Table_21
Vaccinia (adverse events following vaccination) Fetal vaccinia,Contact + Standard,"Until lesions dry and crusted, scabs separated",For contact with virus-containing lesions and exudative material.,Table_21
Vaccinia (adverse events following vaccination) Generalized vaccinia,Contact + Standard,"Until lesions dry and crusted, scabs separated",For contact with virus-containing lesions and exudative material.,Table_21
Vaccinia (adverse events following vaccination) Progressive vaccinia,Contact + Standard,"Until lesions dry and crusted, scabs separated",For contact with virus-containing lesions and exudative material.,Table_21
Vaccinia (adverse events following vaccination) Postvaccinia encephalitis,Standard,n/a,n/a,Table_21
Vaccinia (adverse events following vaccination) Blepharitis or conjunctivitis,Contact + Standard,n/a,Use Contact Precautions if there is copious drainage.,Table_21
Vaccinia (adverse events following vaccination) Iritis or keratitis,Standard,n/a,n/a,Table_21
Vaccinia (adverse events following vaccination) Vaccinia-associated erythema multiforme (Stevens Johnson Syndrome),Standard,n/a,Not an infectious condition.,Table_21
"Vaccinia  (adverse events following vaccination) Secondary bacterial infection (e.g., S. aureus , group A beta hemolytic Streptococcus )",Standard + Contact,n/a,"Follow organism-specific (strep, staph most frequent) recommendations and consider magnitude of drainage.",Table_21
Varicella Zoster,Airborne + Contact + Standard,Until lesions dry and crusted,"Susceptible HCWs should not enter room if immune caregivers are available; no recommendation for face protection of immune HCWs; no recommendation for type of protection (i.e., surgical mask or respirator) for susceptible HCWs. In immunocompromised host with varicella pneumonia, prolong duration of precautions for duration of illness. Varicella Post-exposure Prophylaxis Update [April 2019] Update: Postexposure prophylaxis: provide postexposure vaccine ASAP but within 120 hours; for susceptible exposed persons for whom vaccine is contraindicated (immunocompromised persons, pregnant women, newborns whose mother’s varicella onset is <5 days before delivery or within 48 hours after delivery) provide varicella zoster immune globulin as soon as possible after exposure and within 10 days. Use Airborne for exposed susceptible persons and exclude exposed susceptible healthcare workers beginning 8 days after first exposure until 21 days after last exposure or 28 if received varicella zoster immune globulin, regardless of postexposure vaccination. [1036]",Table_21
Variola (see Smallpox ),n/a,n/a,n/a,Table_21
Vibrio parahaemolyticus (see Gastroenteritis ),n/a,n/a,n/a,Table_21
Vincent’s angina (trench mouth),Standard,n/a,n/a,Table_21
"Viral hemorrhagic fevers due to Lassa, Marburg, Ebola, Crimean-Congo Hemorrhagic Fever, and South American Hemorrhagic Fever viruses (i.e., those caused by Junin, Machupo, Chapare, Guanarito and Sabia viruses) Viral hemorrhagic fevers [September 2024] Update: Precaution recommendations for Viral hemorrhagic fevers have been updated.",See comments,"Duration of precautions should be determined on a case-by-case basis, in conjunction with local, state, and federal health authorities. Factors that should be considered include, but are not limited to, presence of symptoms, date symptoms resolved, other conditions that would require specific precautions (e.g. tuberculosis, Clostridium difficile ) and available laboratory information.",Guidance on Personal Protective Equipment (PPE) in U.S. Healthcare Settings for: Clinically Stable Patients Suspected to have VHF Confirmed Patients and Clinically Unstable Patients Suspected to have VHF,Table_21
Viral respiratory diseases (not covered elsewhere) Adults,Standard,n/a,n/a,Table_21
"Viral respiratory diseases (not covered elsewhere) Infants and young children (see Respiratory infectious disease, acute )",n/a,n/a,n/a,Table_21
Whooping cough (see Pertussis ),n/a,n/a,n/a,Table_22
Wound infections Major,Contact + Standard,Duration of illness,Until drainage stops or can be contained by dressing.,Table_22
Wound infections Minor or limited,Standard,n/a,If dressing covers and contains drainage.,Table_22
Yersinia enterocolitica Gastroenteritis (see Gastroenteritis ),n/a,n/a,n/a,Table_23
Zoster (varicella-zoster) (see Herpes Zoster ),n/a,n/a,n/a,Table_24
"Zygomycosis (phycomycosis, mucormycosis)",Standard,n/a,Not transmitted person-to-person.,Table_24
